title: Depersonalization/derealization disorder after exposure to mefloquine.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD (KM, MSC).
authors.forename: Katherine
authors.initials: K
authors.lastname: McEvoy
authors.affiliation: William H. Welch Medical Library, Baltimore, MD (BA).
authors.forename: Blair
authors.initials: B
authors.lastname: Anton
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD (KM, MSC). Electronic address: mchisol1@jhmi.edu.
authors.forename: Margaret S
authors.initials: MS
authors.lastname: Chisolm
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D000962:Antimalarials / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D003861:Depersonalization / Q000139:chemically induced* / Q000150:complications / Q000628:therapy*; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D015767:Mefloquine / Q000009:adverse effects*; D011613:Psychotherapy; D016896:Treatment Outcome
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000962:Antimalarials; D002121:Calcium Channel Blockers; D015283:Citalopram; D015767:Mefloquine